Lecture 24: Treatments Of Genetic Disease Flashcards

1
Q

What is the largest group of genetic diseases?

A

Inborn errors of metabolism, affect variety of pathways:
- carbohydrate
- fatty acid
- proteins
Lack of enzyme stops production of certain product which can lead to build up of toxic alternate products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How were genetic diseases primarily treated?

A

By controlling diet or replacing what has been lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 stages of drug development?

A

1) Drug discovery
2) Pre-clinical development
3) Clinical development (safe in humans –> therapeutic effect in few patients –> large scale therapeutic trials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which organisation gives approval for drugs to be prescribed by the NHS?

A

NICE (national institute for health and care excellence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do therapies targeting proteins try to do?

A

Try to normalise function of mutant protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are pharmacological chaperones?

A

a drug that acts as a protein chaperone. That is, it contains small molecules that enter cells and serve as a molecular scaffolding in order to cause otherwise-misfolded mutant proteins to fold and route correctly within the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are pharmacological modulators?

A
  • receptor agonists/antagonists

- ion channel activators/blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can diseases caused by non-sense mutations that result in a premature stop codon be treated?

A

Using drugs that can read through specific non-sense mutations to produce some sort of functional protein e.g. turning Duchenne muscular dystrophy into Becker muscular dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the concept of gene therapy?

A

Recessive disease - replace defective gene

Dominant disease - delete defective gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is gene therapy difficult to achieve in practice?

A
  • achieving specificity
  • getting therapy to right place
  • maintain expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is gene therapy easier to achieve in vitro or in vivo?

A

In vitro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is mitochondrially inherited disease therapy?

A

IVF treatment that takes DNA from fertilised patient egg and transfer to donor egg with normal mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Outline virus gene therapy.

A

can engineer virus to carry therapeutic gene

  • virus acts as vector and binds to cell membrane
  • vector packaged in vesicle
  • vesicle breaks down releasing vector
  • vector/virus injects new gene into nucleus
  • cell makes protein using new gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Chimeric Antigen Receptors Cell Therapy (CAR-T)?

A

type of immunotherapy which involves collecting and using the patients’ own immune cells to treat their condition - used to treat cancer
- T-cell receptor antigen bound to MHC
- low affinity
- CAR recognise antigen directly
- variable region monoclonal antibody scFv - recognise cancer cell
- T cell receptor and co-receptor signalling domain work together to kill cancer cells
CAR T cells are able to bind to an antigen on the cancer cells and kill them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Outline how in vivo therapy supplement works.

A
  • useful if patient lacks functional gene
  • use virus to carry in working copy
  • can inject systemically or locally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are antisense oligonucleotides?

A

short, single-stranded DNA molecules that interact with messenger RNA to prevent translation of a targeted gene. Their DNA sequence is complementary to the specific mRNA target; binding leads to degradation of the DNA sequences with failure of protein production

17
Q

Outline how in vivo therapy knockdown therapy works.

A
  • useful for disease caused by gain of function
  • currently no successful therapies
  • principle works using oligonucleotides
  • mutation specific
18
Q

How can exon skipping treat genetic diseases?

A
  • oligonucleotides cause disease-causing exon to be skipped
  • puts RNA back in reading-frame
  • generally only for large proteins
  • useful in limited circumstances
19
Q

What are some possible future therapies?

A
  • gene cell therapy

- gene-editing using CRISPR-Cas9

20
Q

What is CRISPR-Cas9?

A
  • Bacterial ‘immune system’ that can disable bacteriophages
  • Cas9 is endonuclease
  • CRISPR derived from previous bacteriophage
  • recognises and cleaves DNA CRISPR hybrids
21
Q

What can CRISPR-Cas9 do?

A
  • gene editing to correct relatively small errors –> point mutations
  • cannot correct large changes
  • may have off target effects, not currently used in humans
  • same problem as other methods, targeting, getting into cell